Effects of Phytonutrients on Vascular Health
PomPAT
1 other identifier
interventional
32
0 countries
N/A
Brief Summary
This study will determine the effects of beneficial compounds of plant foods, such as pomegranate on cardiovascular health. This will be tested by asking healthy males to eat a high fat ground beef patty with pomegranate juice (PJ), pomegranate extract (PomX) or water and then measuring blood vessel dilation (endothelial function) by blood flow We also will measure the amount of Nitric Oxide (NO) in your blood and urine samples and sugar and insulin in blood. Healthy men have been chosen for this study because eating high fat hamburger patties can easily mimic in them the condition that causes atherosclerosis. The results from this study may help to explain how high fat foods can be harmful to the body and how beneficial plant foods can have on cardiovascular function
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cardiovascular-diseases
Started Jan 2016
Shorter than P25 for not_applicable cardiovascular-diseases
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2015
CompletedFirst Posted
Study publicly available on registry
November 16, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedJanuary 2, 2020
December 1, 2019
8 months
October 12, 2015
December 30, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Abnormal PAT Values That Are Related to Treatment
The major outcomes are PAT changes after a test meal with and without pomegranate.
Change from Baseline vascular function at 6 weeks
Secondary Outcomes (1)
Number of Participants With Abnormal Laboratory Values That Are Related to Treatment
Change from Baseline laboratory values at 6 weeks
Study Arms (3)
Ground beef patty + Water
PLACEBO COMPARATOR32 healthy subjects, ages 18-35 years who meet all the eligibility criteria in the screening phase of the study will receive the ground beef patty + water to evaluate the clinical efficacy of pomegranate on vascular health.Then subjects will be randomized to consume pomegranate juice or extract. At visit 2, subjects will be tested before and after meal with pomegranate juice or extract, then take pomegranate product daily for 4 weeks. At visit 3, subjects will tested before and after test meal with pomegranate products.
Ground beef patty + Pomegranate Extract
ACTIVE COMPARATOR32 healthy subjects, ages 18-35 years who meet all the eligibility criteria in the screening phase of the study will receive the ground beef patty + water to evaluate the clinical efficacy of pomegranate on vascular health.Then subjects will be randomized to consume pomegranate juice or extract. At visit 2, subjects will be tested before and after meal with pomegranate juice or extract, then take pomegranate product daily for 4 weeks. At visit 3, subjects will tested before and after test meal with pomegranate products.
Ground beef patty + Pomegranate Juice
ACTIVE COMPARATOR32 healthy subjects, ages 18-35 years who meet all the eligibility criteria in the screening phase of the study will receive the ground beef patty + water to evaluate the clinical efficacy of pomegranate on vascular health.Then subjects will be randomized to consume pomegranate juice or extract. At visit 2, subjects will be tested before and after meal with pomegranate juice or extract, then take pomegranate product daily for 4 weeks. At visit 3, subjects will tested before and after test meal with pomegranate products.
Interventions
All subjects will consume ground beef patty meal with water at the baseline visit.
Pomegranate Juice will be taken 1/day for 4 weeks.
Pomegranate extract will be taken 1/day for 4 weeks.
Eligibility Criteria
You may qualify if:
- years old males (inclusive)
- Non-smokers
- Must weigh a minimum of 110 pounds
- Willing to maintain normal activity and eating patterns for the duration of the study
- Willing to maintain their normal diet for the duration of the study but avoid pomegranate products and ellagitannin rich foods.
You may not qualify if:
- Any chronic medical conditions
- Abnormal liver function (AST and ALT \> 2 x upper limit)
- Currently taking steroidal drugs
- Cancer treated within the past two years
- Participation in a therapeutic research study within 30 days of baseline
- Use of antibiotics within one month
- Regular use of probiotics
- Allergy or sensitivity to pomegranate products
- Follow a vegetarian diet
- Known HIV positive
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (6)
Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362(6423):801-9. doi: 10.1038/362801a0.
PMID: 8479518BACKGROUNDBonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):168-75. doi: 10.1161/01.atv.0000051384.43104.fc.
PMID: 12588755BACKGROUNDKasprzak JD, Klosinska M, Drozdz J. Clinical aspects of assessment of endothelial function. Pharmacol Rep. 2006;58 Suppl:33-40.
PMID: 17332669BACKGROUNDAnderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwyn AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995 Feb 23;75(6):71B-74B. doi: 10.1016/0002-9149(95)80017-m.
PMID: 7863979BACKGROUNDNohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol (1985). 2006 Aug;101(2):545-8. doi: 10.1152/japplphysiol.01285.2005. Epub 2006 Apr 13.
PMID: 16614356BACKGROUNDBonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, Schnall RP, Holmes DR, Higano ST, Lerman A. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol. 2003 May 21;41(10):1761-8. doi: 10.1016/s0735-1097(03)00329-2.
PMID: 12767662BACKGROUND
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhaoping Li, MD, PhD
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
October 12, 2015
First Posted
November 16, 2015
Study Start
January 1, 2016
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
January 2, 2020
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared with other researchers.